[NOTE: CERTAIN PORTIONS OF THIS DOCUMENT HAVE BEEN MARKED TO INDICATE
CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THIS CONFIDENTIAL
INFORMATION. THESE PORTIONS HAVE BEEN MARKED WITH THE CLAUSE "CONFIDENTIAL
TREATMENT REQUESTED" AND/OR TWO ASTERISKS ENCLOSED IN BRACKETS (i.e., [**]). THE
CONFIDENTIAL PORTIONS HAVE BEEN OMITTED AND FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION.]
REAGENT SUPPLY AGREEMENT
THIS REAGENT SUPPLY AGREEMENT (this "Agreement") is entered into on July 16, 2001, deCODE
GENETICS, ehf., an Icelandic corporation, having offices at Hlidarsmari 15, 200 Kopavogur, Iceland
("deCODE"), and PE CORPORATION (NY), a New York corporation, through its Applied Biosystems
Group, located at 850 Lincoln Centre Drive, Foster City, CA 94404 ("ABG").
A. ABG possesses certain know-how, expertise and technology to manufacture Reagents (as defined below).
B. deCODE desires to purchase Reagents from ABG for certain purposes, including target discovery and
C. ABG has agreed to supply such Reagents to deCODE on the terms and conditions set forth in this
NOW THEREFORE, in consideration of the mutual covenants and consideration set forth herein, and intending
to be legally bound hereby, the parties hereto agree as follows:
1.1 "Contract Year" shall mean each twelve (12) month period throughout the Term commencing on July 1 and
terminating on June 30th of the following calendar year, provided, however, that the First Contract Year shall
commence on the Effective Date hereof.
1.2 "Dollars" or "__DOCTEXT__quot; shall mean United States dollars.
1.3 "Effective Date" shall mean the date first set forth in the first paragraph of this Agreement.
1.4 "Party" or "Parties" shall mean, respectively, ABG or deCODE, and ABG and deCODE.
1.5 "Purchase Price" shall have the meaning assigned to such term in
1.6 "Quarter" means a three month period beginning on or about